Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × sacituzumab govitecan × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Urothelial Bladder Carcinoma 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Metastatic Urothelial Cancer 1 Lung Neoplasms 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1 Laryngeal Neoplasms 1 Klatskin Tumor 1 Hypopharyngeal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Small Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 30 Paclitaxel 12 Carboplatin 10 Cisplatin 7 Pemetrexed 5 Capecitabine 5 Saline Solution 4 Oxaliplatin 4 Gemcitabine 4 Fluorouracil 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 patritumab deruxtecan 3 lenvatinib 3 Leucovorin 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 liposomal doxorubicin 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trastuzumab deruxtecan 1 tislelizumab 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡